This week we highlight an international collaboration for an innovative under-the-skin insulin delivery device, a focus on improving diversity for clinical trials and a promising COVID-19 vaccine for children under 5. Finally, at-home testing for sexually transmitted diseases is coming, and the University ... READ MORE >
Covid-19
5 things to know in life sciences: Week of May 16, 2022
This week we highlight new demand for smallpox vaccines driven by a monkeypox outbreak, the continuing need to improve representation in clinical trials, controlling machines with just your mind, and the lack of combination trials involving a COVID-19 antiviral. Finally, we look at new “smart” contacts ... READ MORE >
5 things to know in life sciences: Week of May 9, 2022
This week we highlight a promising application that leverages artificial intelligence to scan biopsies to help guide cancer treatments. We also look at a novel approach using music to treat multiple sclerosis, a new report that indicates new COVID-19 strains are starting to show a predictable pattern, and ... READ MORE >
RSM US Supply Chain Index: Bracing for more disruptions
Supply chain bottlenecks eased in March, but it won't be for long. Widespread lockdowns in China and prolonged geopolitical conflict in Ukraine will most likely assure another round of supply chain snarls ahead. Our RSM US Supply Chain Index rose 4.5% to 2.76 standard deviation below neutral. The ... READ MORE >
5 things to know in life sciences: Week of April 25, 2022
This week we highlight a bold move to continue clinical trial progress, how the contract research organization industry perceives the state of biotech funding, and machine learning and the fight against long COVID-19. We also weigh COVID-19 risks and a White House event, and the Food and Drug ... READ MORE >
RSM US Manufacturing Outlook Index: Decelerating growth as tensions mount
The deceleration of manufacturing is now in its ninth month, with the RSM US Manufacturing Outlook Index signaling the potential for further economic moderation from rising prices and slowing demand. A deeper dive into the RSM survey suggests that geopolitical uncertainty and a resurgent ... READ MORE >
5 things to know in life sciences: Week of April 18, 2022
This week we highlight new guidance from the U.S. Food and Drug Administration on ensuring that clinical trials are inclusive, Biogen’s challenges with marketing its new Alzheimer’s drug, a COVID-19 breathalyzer and how a new type of T cell could allow better targeting of solid tumors. Finally, we look at ... READ MORE >
What is the yield curve telling us?
Fears of an imminent recession are somewhat overblown. These fears are showing up in fixed-income markets, where investors are betting that the risk of a recession is rising as the economy absorbs a supply shock in the commodity and energy markets and as central banks increase interest rates. But ... READ MORE >
5 things to know in life sciences: Week of March 21, 2022
This week we highlight continued investment in virtual trials, robotic injections, costs of COVID-19 treatments and the need to understand drug safety for pregnant patients. Finally, we look at the most recent round of drug pricing reform in Congress which aims to reduce insulin prices. Each week we ... READ MORE >
The housing market will endure interest rate hikes
Two years into the pandemic, the housing market remains on fire and shows few signs of receding. What was initially fueled by buyers' need for more space and a low interest rate environment has proven to have staying power. Now, with inflation hitting 7.9%, a 40-year high, in February, the Federal ... READ MORE >